SCHEMBL7666136

SCHEMBL7666136

CC(O)COC1CCCC(C)(C(C)C)C1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.30
HTT P42858 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4620512 0.87
SCHEMBL119343 0.86 MEN1 (0.33) MEN1HTTKMT2A
SCHEMBL2363464 0.86 MEN1 (0.33) MEN1HTTKMT2A
SCHEMBL375499 0.86 MEN1 (0.33) MEN1HTTKMT2A
SCHEMBL6563539 0.85 MEN1 (0.33) MEN1HTTKMT2A
SCHEMBL5164194 0.84 MEN1 (0.32) MEN1HTTKMT2A
SCHEMBL4389933 0.81
SCHEMBL15416508 0.81
SCHEMBL4065413 0.81
SCHEMBL11407846 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3103523-B1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION PROCTER & GAMBLE (US) 2025-10-29 EP claimed
US-20250163006-A1 New Coolants, and Preparations Containing Same SYMRISE AG (DE) 2025-05-22 US claimed
US-20250066320-A1 Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same SYMRISE AG (DE) 2025-02-27 US claimed
WO-2025026525-A1 HETEROCYCLIC COMPOUNDS AS PHYSIOLOGICAL COOLANTS SYMRISE AG (DE) 2025-02-06 WO claimed
CN-118984825-A Novel cooling agent and preparation containing same 西姆莱斯股份公司 2024-11-19 CN claimed
EP-4452941-A1 ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2024-10-30 EP claimed
US-20240058259-A1 COMPOSITIONS COMPRISING ESSENTIAL OILS FIRMENICH SA (CH) 2024-02-22 US claimed
US-20240000746-A1 New Cooling Agents and Preparations Containing Them SYMRISE AG (DE) 2024-01-04 US claimed
EP-4247791-A2 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2023-09-27 EP claimed
WO-2023143741-A1 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2023-08-03 WO claimed
WO-2022105986-A1 NOVEL COOLING AGENTS AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2022-05-27 WO claimed
US-20200188289-A1 COMPOSITIONS COMPRISING ESSENTIAL OILS FIRMENICH SA (CH) 2020-06-18 US claimed
CN-110621287-A Composition comprising essential oils 弗门尼舍有限公司 2019-12-27 CN claimed
US-10392371-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2019-08-27 US claimed
US-10336966-B2 Fragrance compositions and uses thereof THE PROCTER & GAMBLE COMPANY (US) 2019-07-02 US claimed
EP-3103431-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF The Procter and Gamble Company (US) 2016-12-14 EP claimed
EP-3103523-A1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION The Procter and Gamble Company (US) 2016-12-14 EP claimed
US-20140328771-A1 METHOD FOR PRODUCING 3-MENTHOXY PROPANOL AND COMPOSITIONS FOR IMPARTING COOLING SENSATION TAKASAGO INTERNATIONAL CORPORATION (JP) 2014-11-06 US claimed
EP-2772477-A1 METHOD FOR PRODUCING 3-MENTHOXY PROPANOL AND COMPOSITION FOR IMPARTING COOLING SENSATION Takasago International Corporation (JP) 2014-09-03 EP claimed
US-6491043-B2 Ultra-low particle semiconductor cleaner SCD MOUNTAIN VIEW, INC. 2002-12-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392371-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM4, TRPM6 MEN1 1052/4885HTT 3860/4885KMT2A 3630/4885
US-20250066320-A1 Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same TAS2R5, TAS2R7, TAS2R8 MEN1 714/4885HTT 1656/4885KMT2A 2748/4885
US-20240000746-A1 New Cooling Agents and Preparations Containing Them TTPA, TREH, TAS2R45 MEN1 1761/4885HTT 1779/4885KMT2A 4030/4885
US-10336966-B2 Fragrance compositions and uses thereof CUTA, DPM1, PLIN5 MEN1 3199/4885HTT 614/4885KMT2A 1921/4885
US-20140328771-A1 METHOD FOR PRODUCING 3-MENTHOXY PROPANOL AND COMPOSITIONS FOR IMPARTING COOLING SENSATION TRPV1, TRPV3, HMOX2 MEN1 261/4885HTT 4109/4885KMT2A 4237/4885
US-20250163006-A1 New Coolants, and Preparations Containing Same TTR, TAS2R5, TAS2R50 MEN1 766/4885HTT 175/4885KMT2A 3992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.